These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30078801)

  • 1. [Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].
    Sanda T
    Rinsho Ketsueki; 2018; 59(7):899-908. PubMed ID: 30078801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.
    Wong RWJ; Ngoc PCT; Leong WZ; Yam AWY; Zhang T; Asamitsu K; Iida S; Okamoto T; Ueda R; Gray NS; Ishida T; Sanda T
    Blood; 2017 Nov; 130(21):2326-2338. PubMed ID: 28978570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.
    Mansour MR; Abraham BJ; Anders L; Berezovskaya A; Gutierrez A; Durbin AD; Etchin J; Lawton L; Sallan SE; Silverman LB; Loh ML; Hunger SP; Sanda T; Young RA; Look AT
    Science; 2014 Dec; 346(6215):1373-7. PubMed ID: 25394790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting General Transcriptional Machinery as a Therapeutic Strategy for Adult T-Cell Leukemia.
    Wong RWJ; Ishida T; Sanda T
    Molecules; 2018 May; 23(5):. PubMed ID: 29724031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
    Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
    Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
    Tan TK; Zhang C; Sanda T
    Int J Hematol; 2019 Jan; 109(1):5-17. PubMed ID: 30145780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes.
    Yu J; Yang Y; Zhou R; Tao Y; Zhu F; Jiao W; Zhang Z; Ji T; Li T; Fang F; Xie Y; Wu D; Zhuo R; Li X; Chen Y; Yin H; Wang J; Pan J
    Carcinogenesis; 2024 Jun; 45(6):424-435. PubMed ID: 38302114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
    Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
    Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
    Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
    Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enhancer RNA
    Tan SH; Leong WZ; Ngoc PCT; Tan TK; Bertulfo FC; Lim MC; An O; Li Z; Yeoh AEJ; Fullwood MJ; Tenen DG; Sanda T
    Blood; 2019 Jul; 134(3):239-251. PubMed ID: 31076442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.
    Liau WS; Ngoc PC; Sanda T
    Adv Exp Med Biol; 2017; 962():139-147. PubMed ID: 28299656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
    Fang F; Lu J; Sang X; Tao YF; Wang JW; Zhang ZM; Zhang YP; Li XL; Xie Y; Wu SY; Chu XR; Li G; Wu D; Chen YL; Yu JJ; Jia SQ; Feng CX; Tian YY; Li ZH; Ling J; Hu SY; Pan J
    J Exp Clin Cancer Res; 2022 Jul; 41(1):225. PubMed ID: 35842703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth.
    Sakamoto H; Ando K; Imaizumi Y; Mishima H; Kinoshita A; Kobayashi Y; Kitanosono H; Kato T; Sawayama Y; Sato S; Hata T; Nakashima M; Yoshiura KI; Miyazaki Y
    Cancer Sci; 2022 Dec; 113(12):4092-4103. PubMed ID: 36047964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
    Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
    Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer. Cancer by super-enhancer.
    Vähärautio A; Taipale J
    Science; 2014 Dec; 346(6215):1291-2. PubMed ID: 25504702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.